Pharma Launch Excellence Summit Pre-Conference Workshop Day: Tuesday 1st December

Pharma Launch Excellence Summit Workshop Day: Monday 1st December 

8:00 am - 9:00 am Registration

Successful launches require more than a strong strategy. They require clear milestones, measurable KPIs, and real-time visibility across every function. This interactive workshop will explore how your team can build a practical launch excellence toolkit to track progress and drive continuous, measurable performance improvement.

• Defining what launch success looks like and establishing meaningful milestones to measure progress
• Discovering KPIs and tracking tools that enable teams to monitor performance, identify gaps, and drive continuous improvement
• Leveraging data and dashboards to provide real-time visibility across critical launch functions, including market access, supply chain, medical affairs, commercial, and regulatory teams
• Creating a unified approach for performance tracking to drive cross-functional alignment and streamline launch execution

img

Elif Tek

Deputy Director - Global Brand Readiness
Bayer AB

img

Oyana Goñi Revuelto

Senior Director, Launch Excellence
Bristol-Myers Squibb

img

Estelle Moritz

Associate Director Launch Excellence, Global Customer Partnership & Supply Orche
Bristol Myers Squibb

10:30 am - 11:00 am Networking Break

11:00 am - 12:30 pm THRIVE Consulting Workshop

1:30 pm - 3:00 pm Defining Clear Priorities for Your Oncology Launch to Gain a Competitive Advantage & Drive Commercial Success

Franck Radenne - Global Launch Lead - Multiple Myeloma, Pfizer

As one of the most competitive therapeutic areas, oncology requires differentiated launch strategies that accelerate patient access, establish an early market presence, demonstrate product value, and drive rapid adoption by healthcare professionals. This workshop will explore how cross-functional excellence, from regulatory and market access to commercial, can accelerate local launches, improve commercial impact, and differentiate products in increasingly crowded markets. 

• Outlining oncology-specific launch challenges and optimising launch plans to overcome them
• Hearing lessons learned from the multiple myeloma launch to identify which strategies to prioritise for strong therapeutic uptake and market adoption
• Identifying how to incorporate patient needs into your launch strategy to ensure effective treatment management in light of adverse events
• Learning practical tips to streamline launch execution, minimise delays, and accelerate patient access following regulatory approval

img

Franck Radenne

Global Launch Lead - Multiple Myeloma
Pfizer